Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Isomaa

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Diabetologia|November 1, 2012
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetesS Alkayyali, M Lajer, H Deshmukh, et al.
Diabetologia|April 18, 2009
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adultsA Jonsson, F Renström, V Lyssenko, et al.
Diabetologia|October 16, 2007
Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretionJ Holmkvist, D Tojjar, P Almgren, et al.
European Journal of Haematology|February 1, 1990
Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala Harja, et al.
Diabetologia|May 20, 2008
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscleT Rönn, P Poulsen, O Hansson, et al.
European Journal of Haematology|October 1, 1989
Treatment of multiple myeloma in old patients. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
European Journal of Haematology|August 1, 1993
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia GroupI P Palva, K Ala-Harja, A Almqvist, et al.
European Journal of Haematology|January 1, 1987
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Diabetes Care|April 24, 2001
Cardiovascular morbidity and mortality associated with the metabolic syndromeB Isomaa, P Almgren, T Tuomi, et al.
Diabetologia|August 10, 2011
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyP Almgren, M Lehtovirta, B Isomaa, et al.
Diabetologia|November 1, 2012
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetesS Alkayyali, M Lajer, H Deshmukh, et al.
Diabetologia|April 18, 2009
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adultsA Jonsson, F Renström, V Lyssenko, et al.
Diabetologia|October 16, 2007
Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretionJ Holmkvist, D Tojjar, P Almgren, et al.
European Journal of Haematology|February 1, 1990
Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala Harja, et al.
Diabetologia|May 20, 2008
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscleT Rönn, P Poulsen, O Hansson, et al.
European Journal of Haematology|October 1, 1989
Treatment of multiple myeloma in old patients. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
European Journal of Haematology|August 1, 1993
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia GroupI P Palva, K Ala-Harja, A Almqvist, et al.
European Journal of Haematology|January 1, 1987
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
Pageof 7